![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, December 14, 2012 3:28:17 PM
If you are right that essentially we are at another starting point, what if a Big Pharma CEO learned of BIEL's devices and mandated a group of his people to do some DD on BIEL?
They would learn that there are no side-effects whatsoever, that BIEL is in the process fo attempting to get FDA approval for OTC sales, that the FDA is in a quandary about BIEL, that there is a chance for approval and drug=free pain management and the stock is cheap.
That said, who has been buying hundreds of millions of shares the last year or so, or is it just MM's in and out to catch a few bucks. If I am top dog at J&J, who was director of their devices division, is it not cheaper to quietly issue a directive to buy shares along the way?
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM